157 related articles for article (PubMed ID: 3256202)
1. [A structural study of the inclusion compound of piroxicam with beta-cyclodextrin by NMR].
Miao ZC; Du ZH; Xu GF; Shi TS
Yao Xue Xue Bao; 1988; 23(9):682-7. PubMed ID: 3256202
[No Abstract] [Full Text] [Related]
2. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
[No Abstract] [Full Text] [Related]
3. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
Chen JY; Tsai WY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the beta-cyclodextrin-hydrocortisone inclusion compound.
Frank SG; Kavaliunas DR
J Pharm Sci; 1983 Oct; 72(10):1215-7. PubMed ID: 6644576
[TBL] [Abstract][Full Text] [Related]
5. Formation of a complex between the analgesic, 6-benzoyl-benzoxazolidinone (CERM 10194), and beta-cyclodextrin.
Si-Nang L; Simond J; Schiff V; Trottier D; Pourrat A
Pharm Acta Helv; 1985; 60(4):112-6. PubMed ID: 4011622
[No Abstract] [Full Text] [Related]
6. Study of products containing mebendazole and beta-cyclodextrin.
Kata M; Papp L
Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409
[No Abstract] [Full Text] [Related]
7. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
[No Abstract] [Full Text] [Related]
8. Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
Szente L; Apostol I; Szejtli J
Pharmazie; 1984 Oct; 39(10):697-9. PubMed ID: 6522449
[TBL] [Abstract][Full Text] [Related]
9. Interaction of beta-cyclodextrin with bile salts in aqueous solutions.
Miyajima K; Yokoi M; Komatsu H; Nakagaki M
Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1395-8. PubMed ID: 3731354
[No Abstract] [Full Text] [Related]
10. Solute-induced circular dichroism: drug discrimination by cyclodextrin.
Han SM; Atkinson WM; Purdie N
Anal Chem; 1984 Dec; 56(14):2827-30. PubMed ID: 6524659
[No Abstract] [Full Text] [Related]
11. Studies of cyclodextrin inclusion complexes: II--Inclusion complexes between alpha-cyclodextrin and N-desmethyldiazepam and chlordiazepoxide.
Aboutaleb AE; Abdel Rahman A; Samy EM
J Pharm Belg; 1988; 43(6):437-44. PubMed ID: 3150006
[No Abstract] [Full Text] [Related]
12. Use of chemically-bonded cyclodextrin stationary phase for high performance liquid chromatographic determination of feldene capsules.
Ahmed AN; el-Gizawy SM
J Chromatogr Sci; 1987 Sep; 25(9):424-6. PubMed ID: 3667839
[TBL] [Abstract][Full Text] [Related]
13. High-field nuclear magnetic resonance techniques for the investigation of a beta-cyclodextrin:indomethacin inclusion complex.
Djedaïni F; Lin SZ; Perly B; Wouessidjewe D
J Pharm Sci; 1990 Jul; 79(7):643-6. PubMed ID: 2398475
[TBL] [Abstract][Full Text] [Related]
14. Monitoring by headspace gaschromatography (HSGC) of formation and thermal stability of terpene beta-cyclodextrin complexes.
Vincieri FF; Mazzi G; Papini P; Gelsomini N
Farmaco Prat; 1986 Mar; 41(3):98-106. PubMed ID: 3709770
[No Abstract] [Full Text] [Related]
15. Inclusion complexes of cinnarizine with beta-cyclodextrin in aqueous solution and in the solid state.
Tokumura T; Ueda H; Tsushima Y; Kasai M; Kayano M; Amada I; Nagai T
Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4179-84. PubMed ID: 6529813
[No Abstract] [Full Text] [Related]
16. The effect of pH dependent molecular conformation and dimerization phenomena of piroxicam on the drug:cyclodextrin complex stoichiometry and its chromatographic behaviour. A new specific HPLC method for piroxicam:cyclodextrin formulations.
Rozou S; Voulgari A; Antoniadou-Vyza E
Eur J Pharm Sci; 2004 Apr; 21(5):661-9. PubMed ID: 15066667
[TBL] [Abstract][Full Text] [Related]
17. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives.
Yoshida A; Yamamoto M; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4075-80. PubMed ID: 3245985
[No Abstract] [Full Text] [Related]
18. Relationships between crystallinity of beta-cyclodextrin and tablet characteristics.
Nakai Y; Yamamoto K; Terada K; Kajiyama A
Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5110-2. PubMed ID: 3830437
[No Abstract] [Full Text] [Related]
19. The potential use of cyclodextrins in parenteral formulations.
Brewster ME; Simpkins JW; Hora MS; Stern WC; Bodor N
J Parenter Sci Technol; 1989; 43(5):231-40. PubMed ID: 2681643
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin complexation of barbiturates in aqueous solution.
Han SM; Purdie N
Anal Chem; 1984 Dec; 56(14):2825-7. PubMed ID: 6524658
[No Abstract] [Full Text] [Related]
[Next] [New Search]
